SPOTLIGHT: Canadians prepare OxyContin lawsuit

OxyContin class action lawsuit
A Canadian lawyer is putting the finishing touches on a class-action lawsuit that pits patients hooked on the pain drug OxyContin against its maker, Purdue Pharma. To be filed in Nova Scotia next week, the suit will claim that the company "misinformed the public and physicians" about OxyContin's suitability for long-term use. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.